PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
“Acute haemorrhagic cystitis occurs in 30 per cent of patients receiving high dose cyclophosphmide . The case highlights that late and severe haemorrhagic cystitis can develop even when cyclophasphamide
Continue reading